Funded Tech Companies
Lactiga Therapeutics
Wondering who invested in Lactiga Therapeutics? 1517 Fund and private investors invested in this biopharmaceutical company.
Company Overview
Company Name
Lactiga Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 King St. West 6000
Toronto Ontario, M5X 1E2
Canada
Toronto Ontario, M5X 1E2
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world's most dangerous pathogens including SARS-CoV-2.
Last Transaction
9/21/2022
Financing History
Date
Type
Amount
Management Team
Company Investors
- 1517 Fund (Zak Slayback)
Browse more funded tech companies:
LactaLogics | Lacuna Technologies
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs